Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions.
Mercadal S, Sancho JM, Climent F, Tapia G, Pomares H, Carro I, Sorigué M, Pané M, Domingo-Doménech E, Encuentra M, Aguilera C, Oliveira AC, Andrade M, Fernández de Sevilla A, Ribera JM, González-Barca E, Sureda A. Mercadal S, et al. Among authors: sureda a. Eur J Haematol. 2020 Mar;104(3):198-206. doi: 10.1111/ejh.13359. Epub 2019 Dec 22. Eur J Haematol. 2020. PMID: 31769545
International and Italian prognostic indices in follicular lymphoma.
Perea G, Altés A, Montoto S, López-Guillermo A, Bosch F, Jiménez M, Esteve J, Domingo E, Ribera JM, Pedro C, Martino R, Briones J, Sureda A, Brunet S, Sierra J, Montserrat E. Perea G, et al. Among authors: sureda a. Haematologica. 2003 Jun;88(6):700-4. Haematologica. 2003. PMID: 12801847
Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol.
Alvarez I, Sureda A, Caballero MD, Urbano-Ispizua A, Ribera JM, Canales M, García-Conde J, Sanz G, Arranz R, Bernal MT, de la Serna J, Díez JL, Moraleda JM, Rubió-Félix D, Xicoy B, Martínez C, Mateos MV, Sierra J. Alvarez I, et al. Among authors: sureda a. Biol Blood Marrow Transplant. 2006 Feb;12(2):172-83. doi: 10.1016/j.bbmt.2005.09.009. Biol Blood Marrow Transplant. 2006. PMID: 16443515 Free article. Clinical Trial.
Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
Rodríguez J, Conde E, Gutiérrez A, Arranz R, Gandarillas M, Leon A, Ojanguren J, Sureda A, Carrera D, Bendandi M, Moraleda J, Ribera JM, Albo C, Morales A, García JC, Fernández P, Cañigral G, Bergua J, Caballero MD; Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea. Rodríguez J, et al. Among authors: sureda a. Eur J Haematol. 2007 Apr;78(4):290-6. doi: 10.1111/j.1600-0609.2007.00815.x. Eur J Haematol. 2007. PMID: 17378891 Free article.
The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma.
Rodríguez J, Conde E, Gutiérrez A, Lahuerta JJ, Arranz R, Sureda A, Zuazu J, Fernández de Sevilla A, Bendandi M, Solano C, León A, Varela MR, Caballero MD; Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea, Spanish Lymphoma/Autologous Bone Marrow Transplant Study Group. Rodríguez J, et al. Among authors: sureda a. Haematologica. 2007 Aug;92(8):1067-74. doi: 10.3324/haematol.11173. Epub 2007 Jul 20. Haematologica. 2007. PMID: 17640855 Free article.
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
Peggs KS, Sureda A, Qian W, Caballero D, Hunter A, Urbano-Ispizua A, Cavet J, Ribera JM, Parker A, Canales M, Mahendra P, Garcia-Conde J, Milligan D, Sanz G, Thomson K, Arranz R, Goldstone AH, Alvarez I, Linch DC, Sierra J, Mackinnon S; UK and Spanish Collaborative Groups. Peggs KS, et al. Among authors: sureda a. Br J Haematol. 2007 Oct;139(1):70-80. doi: 10.1111/j.1365-2141.2007.06759.x. Br J Haematol. 2007. PMID: 17854309 Free article. Clinical Trial.
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Avivi I, Montoto S, Canals C, Maertens J, Al-Ali H, Mufti GJ, Finke J, Schattenberg A, Fanin R, Cornelissen JJ, Vernant JP, Russell N, Beguin Y, Thomson K, Verdonck LF, Kobbe G, Tilly H, Socié G, Sureda A; EBMT Lymphoma Working Party. Avivi I, et al. Among authors: sureda a. Br J Haematol. 2009 Dec;147(5):719-28. doi: 10.1111/j.1365-2141.2009.07905.x. Epub 2009 Sep 30. Br J Haematol. 2009. PMID: 19793383 Free article.
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sureda A, Canals C, Arranz R, Caballero D, Ribera JM, Brune M, Passweg J, Martino R, Valcárcel D, Besalduch J, Duarte R, León A, Pascual MJ, García-Noblejas A, López Corral L, Xicoy B, Sierra J, Schmitz N. Sureda A, et al. Haematologica. 2012 Feb;97(2):310-7. doi: 10.3324/haematol.2011.045757. Epub 2011 Oct 11. Haematologica. 2012. PMID: 21993674 Free PMC article. Clinical Trial.
Hematopoietic stem cell transplantation in patients with lymphomatoid granulomatosis: a European group for blood and marrow transplantation report.
Siegloch K, Schmitz N, Wu HS, Friedrichs B, van Imhoff GW, Montoto S, Holler E, Ribera JM, Delage R, Dührsen U, Castillo N, Harrison B, Dreger P, Sureda A; Working Party Lymphoma of the European Group for Blood and Marrow Transplantation (EBMT). Siegloch K, et al. Among authors: sureda a. Biol Blood Marrow Transplant. 2013 Oct;19(10):1522-5. doi: 10.1016/j.bbmt.2013.07.023. Epub 2013 Aug 13. Biol Blood Marrow Transplant. 2013. PMID: 23948061 Free article.
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
Klyuchnikov E, Bacher U, Kröger NM, Hari PN, Ahn KW, Carreras J, Bachanova V, Bashey A, Cohen JB, D'Souza A, Freytes CO, Gale RP, Ganguly S, Hertzberg MS, Holmberg LA, Kharfan-Dabaja MA, Klein A, Ku GH, Laport GG, Lazarus HM, Miller AM, Mussetti A, Olsson RF, Slavin S, Usmani SZ, Vij R, Wood WA, Maloney DG, Sureda AM, Smith SM, Hamadani M. Klyuchnikov E, et al. Among authors: sureda am. Biol Blood Marrow Transplant. 2015 Dec;21(12):2091-2099. doi: 10.1016/j.bbmt.2015.07.028. Epub 2015 Aug 4. Biol Blood Marrow Transplant. 2015. PMID: 26253007 Free PMC article.
881 results